Sabby Management, LLC

Name: SABBY MANAGEMENT, LLC 13F holdings, Q2 2026
Creator: SABBY MANAGEMENT, LLC
Published: 2026-08-14

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), Sabby Management, LLC reported 14 stock positions worth $11.8 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 34.7% of the portfolio, followed by Toyo (TOYO, 29.6%) and Farmmi Class A (FAMI, 7.1%). Compared with Q1 2026, it opened 8 new positions, sold out of 14, added to 4 and reduced 2. The biggest buy was a new position in Toyo (TOYO) and the biggest sale an exit from Alpha Compute (ALP).

Most Recent 13F: Q2 2026
Location: MIAMI BEACH, FL
CIK: 0001535610
Portfolio Value: $11.8M (Q2 2026)
SEC Filing: 0001104659-26-096397 ↗ filed Aug 14, 2026

Holdings Value

Holdings 14 stocks · $11.8M


SPY SS SPDR S&P 500 ETF Trust-US	34.69%	5,500	$4.1M	Add +101.2%
TOYO Toyo Co. Ltd.	29.58%	503,846	$3.5M	New
FAMI Farmmi Inc. Class A	7.10%	3,515,929	$840K	New
CRVO Cervomed Inc.	6.52%	248,880	$772K	New
TPST Tempest Therapeutics Inc.	4.79%	511,286	$568K	Add +2763.4%
PAVS Paranovus Entertainment Tech	4.73%	75,440	$561K	New
BIOAFFINITY TECHNOLOGIES INC	2.51%	365,647	$297K	New
CREG Smart Powerr Corp.	2.22%	127,774	$263K	New
BCTX Briacell Therapeutics Corp.	2.21%	80,721	$262K	Add +9.2%
REVB Revelation Biosciences Inc.	1.83%	210,582	$217K	Add +111.8%
SNES Senestech Inc.	1.78%	141,756	$211K	Reduce -35.1%
SIDU Sidus Space Inc. Class A	1.03%	43,377	$122K	New
INM Inmed Pharmaceuticals Inc.	0.59%	44,970	$70K	Reduce -79.6%
NUWE Nuwellis Inc.	0.42%	16,372	$50K	New

Options reported separately and not counted above: STATE STR SPDR S&P 500 ETF T puts ($54.1M), STATE STR SPDR S&P 500 ETF T calls ($15.3M), ISHARES TR calls ($13.3M), ISHARES TR puts ($13.2M), ABIVAX SA calls ($1.1M), SIDUS SPACE INC puts ($816K), ZEVRA THERAPEUTICS INC puts ($612K).

Other holdings (2): bonds, preferreds, convertibles and warrants · $181K (not counted above)

Security	Class	Shares / Principal	Value	Change
BCTXL Briacell Therapeutics Corp.	*W EXP 01/15/203	190,383	$169K	Reduce -50.0%
BCTXZ Briacell Therapeutics - 30	*W EXP 99/99/999	120,802	$11K	Reduce -41.6%

Total filed on the 13F, all lines: $12.0M.

Portfolio Sells Q1 2026 → Q2 2026


ALP Alpha Compute Corp.	Sold out	0.00%	−12.38
DSY Big Tree Cloud Holdings LT-A	Sold out	0.00%	−6.37
SNES Senestech Inc.	Reduce -35.1%	1.78%	−4.99
TC Token Cat Ltd.	Sold out	0.00%	−4.57
CPOP Pop Culture Group Co. Ltd. Class A	Sold out	0.00%	−3.80
MBRX Moleculin Biotech Inc.	Sold out	0.00%	−3.25
BDRX Biodexa Pharmaceuticals PLC	Sold out	0.00%	−3.01
RKDA Arcadia Biosciences Inc.	Sold out	0.00%	−2.99
TRX TRX Gold Corp.	Sold out	0.00%	−2.84
CANF Can Fite Biopharma Ltd.-ADR	Sold out	0.00%	−2.49
SXTC China SXT Pharmaceuticals-A	Sold out	0.00%	−2.48
INM Inmed Pharmaceuticals Inc.	Reduce -79.6%	0.59%	−2.10
CLDI Calidi Biotherapeutics Inc.	Sold out	0.00%	−1.96
BJDX Bluejay Diagnostics Inc.	Sold out	0.00%	−1.00
LYRA Lyra Therapeutics Inc.	Sold out	0.00%	−0.97
BNBX BNB Plus Corp.	Sold out	0.00%	−0.16

Portfolio Buys Q1 2026 → Q2 2026


TOYO Toyo Co. Ltd.	New	29.58%	+29.58
FAMI Farmmi Inc. Class A	New	7.10%	+7.10
CRVO Cervomed Inc.	New	6.52%	+6.52
PAVS Paranovus Entertainment Tech	New	4.73%	+4.73
TPST Tempest Therapeutics Inc.	Add +2763.4%	4.79%	+4.24
BIOAFFINITY TECHNOLOGIES INC	New	2.51%	+2.51
CREG Smart Powerr Corp.	New	2.22%	+2.22
SPY SS SPDR S&P 500 ETF Trust-US	Add +101.2%	34.69%	+1.08
SIDU Sidus Space Inc. Class A	New	1.03%	+1.03
NUWE Nuwellis Inc.	New	0.42%	+0.42
REVB Revelation Biosciences Inc.	Add +111.8%	1.83%	−0.42
BCTX Briacell Therapeutics Corp.	Add +9.2%	2.21%	−3.65

Options Activity Q1 2026 → Q2 2026


STATE STR SPDR S&P 500 ETF T	put	Add +62.2%	725	$54.1M
STATE STR SPDR S&P 500 ETF T	call	New	205	$15.3M
ISHARES TR	call	New	442	$13.3M
ISHARES TR	put	Add +47.0%	441	$13.2M
GEVO INC	put	Sold out	5,252	$1.4Mbefore exit
ABIVAX SA	call	Add +6.5%	82	$1.1M
SIDUS SPACE INC	put	Add +176.9%	2,905	$816K
ZEVRA THERAPEUTICS INC	put	Add +25.6%	427	$612K

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

Notes & Other Activity Q1 2026 → Q2 2026


BCTXL Briacell Therapeutics Corp.	*W EXP 01/15/203	Reduce -50.0%	190,383	$169K
BCTXZ Briacell Therapeutics - 30	*W EXP 99/99/999	Reduce -41.6%	120,802	$11K

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

Quarter	Positions	13F Reported Value	Top Holdings
Q2 2026	14	$11.8M	SPY, TOYO, FAMI, CRVO, TPST
Q1 2026	20	$5.3M	SPY, ALP, SNES, DSY, BCTX
Q4 2025	24	$11.9M	DSY, EMPD, BLNK, BITCOIN DEPOT INC, ABVX
Q3 2025	28	$19.1M	DSY, EMPD, CPOP, EVEX, CAN FITE BIOFARMA LTD
Q2 2025	32	$12.4M	TPST, EOSE, LYRA, LEXX, CAN FITE BIOFARMA LTD
Q1 2025	36	$23.8M	SRFM, IWM, LLY, EOSE, KSCP
Q4 2024	15	$12.3M	EOSE, SPY, IWM, VANI, BTBT
Q3 2024	24	$7.2M	VANI, VOLCON INC, HEALTHY CHOICE WELLNESS CORP, IMNN, CORZ
Q2 2024	22	$6.7M	VANI, RDHL, GREENWAVE TECHNOLOGY SOLUTIO, ELTK, IWM
Q1 2024	36	$13.9M	VANI, ELTK, RDHL, TNXP, GMM